Health Care Supplies

Tianyi Medical

Tianyi Medical released FY2025 annual earnings on April 22 After-Market (BJT), actual revenue CNY 575.76 M (forecast CNY 540.2 M), actual EPS CNY -0.28 (forecast CNY 1.7)

Tianyi Medical released FY2026 Q1 earnings on April 22 After-Market BJT, actual revenue CNY 163.87 M, actual EPS CNY 0.1579

Tianyi Medical released FY2025 Q4 earnings on April 22 After-Market (BJT), actual revenue CNY 188.7 M, actual EPS CNY -0.6673

Tianyi Medical to Release FY2026 Q1 Earnings on April 23 After-Market (BJT)

Tianyi Medical to Release FY2025 Earnings on April 23 After-Market (BJT), Forecast Revenue CNY 540.2 M, EPS CNY 1.7

Tianyi Medical released FY2025 Q3 earnings on October 26 After-Market (BJT), actual revenue CNY 159.73 M, actual EPS CNY 0.1805

Tianyi Medical released FY2025 9 Months earnings on October 26 After-Market BJT, actual revenue CNY 387.05 M, actual EPS CNY 0.3406

Tianyi Medical to Release FY2025 Q3 Earnings on October 27 After-Market BJT

Tianyi Medical released FY2025 Q2 earnings on August 27 Pre-Market (BJT), actual revenue CNY 128.8 M, actual EPS CNY 0.0773

Tianyi Medical released FY2025 Semi-Annual Earnings on August 27 Pre-Market (BJT), Actual Revenue: CNY 227.32 M, Actual EPS: CNY 0.16

Tianyi Medical to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Tianyi Medical Responds to EU Restrictions on Chinese Medical Devices

Tianyi Medical Fully Owns the Establishment of Beijing Tianyi Medical Device Co., Ltd.

Tianyi Medical's ESG Rating Results Released

Tianyi Medical Obtains Medical Device Registration Certificate

Tianyi Medical Reports Revenue of 98.5126 Million Yuan in Q1 2025

Tianyi Medical released FY2025 Q1 earnings on April 27 After-Market (BJT), actual revenue CNY 98.51 M, actual EPS CNY 0.0827

Tianyi Medical FY2025 Q1 Earnings Release Scheduled for April 28 After-Market BJT

Tianyi Medical released FY2024 Q4 earnings on April 14 After-Market BJT, actual revenue CNY 107.18 M, actual EPS CNY -0.0568

Tianyi Medical released FY2024 annual earnings on April 14 After-Market BJT, actual revenue CNY 418.96 M (forecast CNY 422.16 M), actual EPS CNY -0.01 (forecast CNY 0.41)

301097

002901

688108

300981

688026

603880

The medical consumables sector has undergone significant adjustments, with SINOMED hitting the limit down, and Tianyi Medical, Double Medical, Guoke Hengtai, ZHYL, Jet Bio-Filtration, and NANFANG MEDICAL also following suit

Zhitong

Double Medical

SINOMED

ZHYL

Jet Bio-Filtration

NANFANG MEDICAL

The medical consumables sector has undergone significant adjustments, with SINOMED hitting the limit down

Tianyi Medical released its third-quarter report for 2025, with operating revenue for the first three quarters reaching 387 million yuan, a year-on-year increase of 24.14%. The net profit attributable to the parent company was 20.0941 million yuan, a year-on-year increase of 216.81%. The net profit after deducting non-recurring gains and losses was 8.4059 million yuan, a year-on-year increase of 762.11%. The basic earnings per share were 0.34 yuan

Tianyi Medical released its performance for the first three quarters, with a net profit attributable to the parent company of 20.0941 million yuan, an increase of 216.81%

Tianyi Medical announced that the actual controller Wu Bin has lifted the pledge of 4.5 million shares and re-pledged the same number of shares. The lifted pledged shares account for 37.50% of his holdings and 7.63% of the company's total share capital. The pledge start date is September 8, 2025, and the expiration date is September 3, 2030. The pledgee is China CITIC Bank Ningbo Branch, and the purpose of the pledge is for personal funding needs

Tianyi Medical: Shareholder Wu Bin pledges 4.5 million company shares

On the evening of June 5th, Tianyi Medical announced that the company recently received the "Medical Device Registration Certificate" for disposable continuous renal replacement therapy tubing and disposable hemodialysis tubing issued by the National Medical Products Administration. The acquisition of this registration certificate will further enrich the company's product variety and enhance its market competitiveness

Tianyi Medical: The company's products have obtained medical device registration certificates

According to the announcement from Tianyi Medical, the company plans to distribute a cash dividend of RMB 5.00 (tax included) for every 10 shares to all shareholders in the year 2024. The record date for this equity distribution is May 15, 2025, and the ex-dividend date is May 16, 2025

Tianyi Medical plans to distribute 5 yuan for every 10 shares for the year 2024, with the ex-dividend date on May 16

Tianyi Medical recently obtained the "Medical Device Registration Certificate" issued by the Zhejiang Provincial Drug Administration, with the registered product being a disposable enteral nutrition syringe. This product is manufactured in a sterile state, sterilized with ethylene oxide, and includes an outer sleeve, core rod, piston, and optional protective cap, meeting relevant material standards. This registration will enrich the company's product variety, enhance market competitiveness, and support the company's development

Tianyi Medical: Single-use enteral nutrition syringe obtained product registration certificate

According to the Zhitong Finance APP, Tianyi Medical released its Q1 2025 report, showing an operating income of 98.5126 million yuan, a year-on-year increase of 1.65%. The net profit attributable to shareholders of the listed company was 4.8761 million yuan, a year-on-year decrease of 9.81%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 520,700 yuan. The basic earnings per share were 0.0827 yuan

Tianyi Medical released its first-quarter performance, with a net profit attributable to the parent company of 4.8761 million yuan, a decrease of 9.81%

Tianyi Medical released its 2024 annual report, with operating revenue of 419 million yuan, a year-on-year increase of 9.98%. However, the net loss attributable to shareholders of the listed company was 744,000 yuan, and the net loss after deducting non-recurring gains and losses was 10.4131 million yuan, with a basic loss per share of 0.01 yuan. The company plans to distribute a cash dividend of 5.00 yuan (including tax) for every 10 shares to all shareholders. The consolidated net profit for 2024 decreased by 101.17% compared to 2023

Tianyi Medical released its 2024 annual performance, turning from profit to a loss of 744,000 yuan

Tianyi Medical, through its wholly-owned subsidiary Pulaimaklong International Limited, intends to acquire the CRRT-filter business assets of BELLCO S.R.L. for EUR 11.99 million. This transaction will enable Tianyi Medical to form a complete CRRT product line, becoming the third company to have a full range of CRRT products, thereby enhancing its global market expansion capabilities

Fresenius Medical Care

Tianyi Medical plans to acquire CRRT-filter assets for €11.99 million to improve its production line

Tianyi Medical(301097.SZ)